Neurocentria, Inc.
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder (NCT06673368) | Neurocentria, Inc. | 2025-02-25 |
| Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD (NCT06215144) | Neurocentria, Inc. | 2024-01-25 |
| Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD) (NCT05683249) | Neurocentria, Inc. | 2023-02-25 |
| Comparison of MMFS Dosages in Older Adults (NCT03601169) | Neurocentria, Inc. | 2018-07-23 |
| Efficacy and Safety of MMFS in Early AD (NCT03531684) | Neurocentria, Inc. | 2018-03-20 |
Track Neurocentria, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.